Oral rapamycin in the treatment of diffuse proliferative in-stent restenosis in a patient with small reference vessel

J Invasive Cardiol. 2003 Sep;15(9):515-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Angioplasty, Balloon, Coronary / adverse effects*
  • Coronary Restenosis / drug therapy*
  • Coronary Restenosis / etiology*
  • Coronary Restenosis / therapy
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Middle Aged
  • Sirolimus / administration & dosage*
  • Stents / adverse effects*

Substances

  • Immunosuppressive Agents
  • Sirolimus